PLUS500
Plus500 Ltd., a leading online service provider for retail customers to trade CFDs internationally, is pleased to announce that it has entered into a sponsorship agreement with Liga BBVA champions, Club Atlético de Madrid, SAD, to be an Official Sponsor for the remainder of the 2014/15 season, with both parties actively considering extending and expanding the relationship for further seasons.
As part of the agreement, the Plus500 logo will feature as Official Sponsor on the back of the home and away Atlético Madrid shirts for national matches. Plus500 will enjoy a range of branding rights at the stadium and beyond as well as a host of other sponsorship benefits.
Plus500 is a provider of a leading online trading platform for contracts for difference (CFDs), which enables customers to trade on movements in the price of shares, forex, commodities and indices without needing to buy or sell the underlying instrument. In total, customers can trade on more than 2,100 different underlying global financial instruments in over 50 countries. The trading platform, which has been developed by Plus500 and is based on proprietary technology, is accessible from multiple operating systems and has been localised into over 31 languages.
Atlético Madrid is a Spanish professional football club based in Madrid that plays in Liga BBVA, commonly known as ‘La Liga’, which is the top professional association football division of the Spanish football league system. The club is the current champion of La Liga after winning the 2013/14 season – representing its tenth victory of the competition. Atlético Madrid has won the Copa del Rey on ten occasions along with other Spanish cup competitions. It is also one of the most successful clubs in Europe, including winning the UEFA Super Cup in 2010 and 2012, and coming second in the 2013/14 UEFA Champions League. Atlético Madrid resides at the Vicente Calderón stadium, which has capacity for almost 55,000 spectators, and in the near-future will be moving to a new, state-of-the-art stadium that will have a capacity of around 70,000.
According to UEFA’s league coefficient, La Liga has been the strongest league in Europe over the past five years as well as the top league in Europe for more years combined (16 years) than any other European league. In addition, it is one of the most popular professional sports leagues in the world, with the third-highest average match attendance figures for 2013/14 of any professional association football league and eighth-highest of any domestic professional sports league worldwide.
Gal Haber, Chief Executive Officer of Plus500, said: “We are honoured to be partnering with such an esteemed football club as Atlético Madrid, which has established a strong pedigree over its 111 year history. Atlético Madrid is a natural fit for us as Europe is our largest customer base, and we share with them a passion for striving for success whilst having an ethos of transparency and respect for our customers, fans, partners and employees. In addition, this partnership with one of the most successful clubs in Europe that plays in one of the most popular leagues in the world will help us in furthering our strategy of increasing our brand recognition and expanding our customer base globally.”
Miguel Ángel Gil Marín, Chief Executive Officer of Atlético Madrid, added: “We are delighted to have entered into this agreement with Plus500. This is an exciting period for the club as – like Plus500 – we grow our international footprint. We believe that this partnership with Plus500 will support this progress, and we look forward to sharing our journey with them as we embark on a new chapter for Atlético de Madrid.”
About Plus500
Plus500 has developed and operates an online trading platform for retail customers to trade CFDs internationally over more than 2,100 different underlying global financial instruments comprising equities, ETFs, foreign exchange, indices and commodities. The Company enables retail customers to trade CFDs in more than 50 countries. The trading platform is accessible from multiple operating systems (Window, smartphones (iOS and Android) and tablets (iOS and Android)) and the internet. The Directors believe that the success of the Company to date has been primarily due to the proprietary technology it has developed and continues to develop to support the trading platform. The trading platform has been designed to be as intuitive and easy to use as possible. The trading platform has been localised into over 31 languages. The Directors believe that this emphasis on technology, together with the Company’s targeted online marketing strategy, has helped to differentiate the Company from its competitors.
The Company is listed on AIM, a market operated by the London Stock Exchange plc, under the trading symbol ‘PLUS’.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150107005132/en/
Contact:
Plus500
Elad Even-Chen, +972 4 8189503
VP Business
Development and Head of Investor Relations
ir@Plus500.com
or
Liberum
Capital
Chris Bowman, +44 20 3100 2222
or
Luther
Pendragon
Harry Chathli, Claire Norbury, Alexis Gore, Nick
Corrin, +44 20 7618 9100
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Prodalim Expands its Natural Ingredients Portfolio with the Launch of Coloring Foodstuffs and Natural Colors Product Lines, Enhancing Innovation in Upcycled Products16.7.2025 12:18:00 CEST | Press release
Prodalim, a global leader in juice solutions and specialty ingredients, announces the launch of its Coloring Foodstuffs and Natural Colores portfolio, marking a milestone in its commitment to delivering clean-label, plant-based, upcycled product innovations for the food and beverage industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716821011/en/ These natural color solutions are designed for seamless integration into a wide range of applications, including beverages, dairy, plant-based products, bakery, and confectionery. They offer vibrant visual appeal without compromising on performance, health standards, regulatory compliance, or consumer trust. Developed based on strict quality standards, Prodalim’s Coloring portfolio delivers optimal light resistance, pH stability, and thermal performance, addressing real-world formulation challenges while enhancing naturality, clean label credentials, and full “tree-to-table
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum